[1]Bulum J, Ernst A, Strozzi M. The impact of successful manual thrombus aspiration on in-stent restenosis after primary PCI:angiographic and clinical follow-up[J]. Coron Artery Dis, 2012,23(23): 487-491.
[2]Song M, Shen HT, Cui JJ, et al. A novel model of intimal hyperplasia with graded hypoosmotic damage[J].Cardiovasc Pathol,2012,21(6): 490-498.
[3]Alexand MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease[J]. Annu Rev Physiol, 2012,74: 13-40.
[4]Yang X, Huang CG, Du SY, et al. Effect of Danggui Buxue Tang on immune-mediated aplastic anemia bone marrow proliferation mice[J]. Phytomedicine, 2014,21(5): 640-646.
[5]Li YD, Ma YH, Zhao JX, et al. Protection of ultra-filtration extract from Danggui Buxue Decoction on oxidative damage in cardiomyocytes of neonatal rats and its mechanism[J]. Chin J Integr Med, 2011,17(11): 854-859.
[6]张志斌,陆曙,周春刚,等.当归补血汤对大鼠动脉内皮细胞凋亡的干预作用[J].中国实验方剂学杂志,2013,19(3): 215-218.
[7]秦瑧,黄水清.当归补血汤对动脉样硬化兔内皮祖细胞及血清VEGF、SDF-1的影响[J].中国病理生理杂志,2012,28(2): 211-215.
[8]Li F, Tang R, Chen LB, et al. Effects of astragalus combined with angelica on bone marrow hematopoiesis suppression induced by cyclophosphamide in mice[J]. Biol Pharm Bull, 2017, 40(5): 598-609.
[9]彭熙炜,阎卉芳,黄娟,等. 黄芪-当归不同配伍比例对大鼠血管内膜增生的影响[J]. 中国中医药信息杂志,2017,24(6):56-59.
[10]Wu L, Zhang W, Li H, et al. Inhibition of aortic intimal hyperplasia and cell cycle protein and extracellular matrix protein expressions by BuYang HuanWu Decoction[J].J Ethnopharmacol, 2009,125(3): 423-435.
[11]Wu L, Zhang W, Tang YH, et al. Effect of total saponins of "panax notoginseng root" on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats[J]. Phytomedcine, 2010,17(3/4):233-240.
[12]Watson T,Goon PK,Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation and oxidative stress in hypertension[J]. Antioxid Redox Sign, 2008, 10(8): 1079-1088.
[13]Bae JH, Bassenge E, Kim KY, et al. Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention with stenting[J]. J Cardiovasc Pharmacol Ther, 2004, 9(3): 185-192.
[14]Faries PL, Rohan DI, Wyers MC, et al. Vascular smooth muscle cells derived from atherosclerotic human arteries exhibit greater adhesion, migration, and proliferation than venous cells[J].J Surg Res, 2002,104(1):22-28.
[15]Regan CP, Adam PJ, Madsen CS, et al. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury[J]. J Clin I nvest, 2000, 106(9):1139-1147.
[16]Miniati DN, Hoyt EG, Feeley BT, et al. Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease[J]. Circulation, 2000, 102(3): 237-242.
[17]Xiao B, Spencer J, Clements A, et al. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and themolecular basis of its regulation[J]. Proc Natl Acad Sci USA,2003,100(5): 2363-2368.
[18]Mehta RR, Yamada T, Taylor BN, et al. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt[J]. Angiogenesis,2011,14(3):355-369.
[19]Morello F, Perino A, Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system[J]. Cardiovasc Res, 2009, 82(2):261-271. |